Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

Fbxo12J Activators

Fbxo12J Activators refer to a category of chemical agents designed to modulate the functional activity of a protein presumed to be part of the F-box protein family, specifically Fbxo12J. This protein is implicated in the process of ubiquitination, a cellular mechanism where proteins are tagged with ubiquitin molecules, marking them for various fates within the cell, most notably for degradation by the proteasome. The activators within this chemical class are not direct stimulators of the Fbxo12J protein itself but instead work by altering the cellular environment in which Fbxo12J operates. Their primary mode of action involves intervening in the ubiquitin-proteasome system (UPS), either by inhibiting the proteasome's ability to degrade ubiquitin-tagged proteins or by disrupting upstream ubiquitination processes. As a result, these compounds lead to an accumulation of proteins that would typically be processed by the proteasome, thus indirectly enhancing the demand for Fbxo12J's ubiquitination activity.

The intricate balance of protein synthesis and degradation is critical for cellular homeostasis, and Fbxo12J is an important part of this regulation. The compounds classified as Fbxo12J Activators contribute to a shift in this balance by several mechanisms. Some of these chemicals act as proteasome inhibitors, which leads to a build-up of proteins that have been tagged for degradation but are unable to be processed due to the inhibited proteasome function. This accumulation can signal the need for increased ubiquitination activity, potentially augmenting the role of Fbxo12J. Other molecules in this class target enzymes responsible for the initial steps in the ubiquitination cascade, such as the ubiquitin-activating E1 enzyme and the NEDD8-activating enzyme. By inhibiting these enzymes, the activators cause an increase in the levels of proteins that require ubiquitination, again indirectly necessitating enhanced Fbxo12J function.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Ubiquitin E1 Inhibitor, PYR-41

418805-02-4sc-358737
25 mg
$360.00
4
(1)

An irreversible inhibitor of ubiquitin-activating enzyme (E1), leading to increased levels of unubiquitinated proteins, which could enhance the activity of Fbxo12J to compensate for the disrupted ubiquitination.

MLN 4924

905579-51-3sc-484814
1 mg
$286.00
1
(0)

An inhibitor of NEDD8-activating enzyme, preventing cullin-RING ligase activation, possibly leading to an accumulation of Fbxo12J substrates and enhanced Fbxo12J-mediated ubiquitination in response.

Lactacystin

133343-34-7sc-3575
sc-3575A
200 µg
1 mg
$188.00
$575.00
60
(2)

A specific inhibitor of the proteasome, it may enhance Fbxo12J activity by increasing the pool of proteins that require ubiquitination for subsequent degradation.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

A proteasome inhibitor used to increase the levels of proteins in cells, potentially enhancing the demand for Fbxo12J’s ubiquitination activity.

IU1

314245-33-5sc-361215
sc-361215A
sc-361215B
10 mg
50 mg
100 mg
$138.00
$607.00
$866.00
2
(0)

A specific inhibitor of the deubiquitinating enzyme USP14, which can lead to an increase in ubiquitinated proteins, indirectly enhancing the functional activity of Fbxo12J.

Epoxomicin

134381-21-8sc-201298C
sc-201298
sc-201298A
sc-201298B
50 µg
100 µg
250 µg
500 µg
$137.00
$219.00
$449.00
$506.00
19
(2)

A selective and potent proteasome inhibitor that could indirectly cause an increase in Fbxo12J activity due to increased substrate levels.

Oprozomib

935888-69-0sc-477447
2.5 mg
$280.00
(0)

An orally bioavailable proteasome inhibitor, which could lead to an upregulation of Fbxo12J’s activity in response to increased levels of proteins requiring ubiquitination.

Carfilzomib

868540-17-4sc-396755
5 mg
$41.00
(0)

A proteasome inhibitor that can lead to increased ubiquitinated proteins and potentially enhance the activity of Fbxo12J as part of the cellular response.

Withaferin A

5119-48-2sc-200381
sc-200381A
sc-200381B
sc-200381C
1 mg
10 mg
100 mg
1 g
$130.00
$583.00
$4172.00
$20506.00
20
(1)

A steroidal lactone that has been shown to inhibit the proteasomal pathway, which could indirectly enhance Fbxo12J activity due to increased ubiquitin-conjugated proteins.